RevyPro

RevyPro® is a systemic fungicide with protectant and curative properties for disease control in winter wheat, spring wheat, durum wheat, spelt wheat, winter barley, spring barley, winter rye, spring rye, winter triticale and spring triticale.

RevyPro

RevyPro® is a systemic fungicide with protectant and curative properties for disease control in winter wheat, spring wheat, durum wheat, spelt wheat, winter barley, spring barley, winter rye, spring rye, winter triticale and spring triticale.

Product Overview
Label

RevyPro Label

Safety data sheet

RevyPro MSDS

RevyPro NI MSDS

Product Details

Active ingredient(s)50 g/l mefentrifluconazole and 100 g/l prothioconazole
FormulationEmulsifiable concentrate (EC)
Pack Size5 litres in outers of four
CropsWinter wheat, spring wheat, durum wheat, spelt wheat, winter barley, spring barley, winter rye, spring rye, winter triticale and spring triticale
Disease ActivityBroad spectrum including Septoria tritici, yellow rust, brown rust, tan spot, eyespot, Fusarium ear blight, powdery mildew, net blotch, Rhynchosporium and Ramularia
Maximum individual dose1.5 litres per hectare
Maximum total dose1.5 litres per hectare
Maximum number of treatmentsOne
Latest time of applicationWhen flowering anthesis complete (GS 69)
Water volume100-400 litres per hectare
Aquatic buffer zone5 m
Other specific restrictionsThis product must not be applied via hand-held equipment
Active ingredient(s)50 g/l mefentrifluconazole and 100 g/l prothioconazole
FormulationEmulsifiable concentrate (EC)
Pack Size5 litres in outers of four
CropsWinter wheat, spring wheat, durum wheat, spelt wheat, winter barley, spring barley, winter rye, spring rye, winter triticale and spring triticale
Disease ActivityBroad spectrum including Septoria tritici, yellow rust, brown rust, tan spot, eyespot, Fusarium ear blight, powdery mildew, net blotch, Rhynchosporium and Ramularia
Maximum individual dose1.5 litres per hectare
Maximum total dose1.5 litres per hectare
Maximum number of treatmentsOne
Latest time of applicationWhen flowering anthesis complete (GS 69)
Water volume100-400 litres per hectare
Aquatic buffer zone5 m
Other specific restrictionsThis product must not be applied via hand-held equipment

Why RevyPro?

RevyPro® is a new fungicide option for spring 2025. RevyPro combines Revysol® and prothioconazole to deliver flexibility and robust disease control in both wheat and barley.

RevyPro® in Barley

RevyPro® combines the best two azoles for barley to provide well balanced disease control covering all major barley diseases; net blotch, Rhynchosporium and ramularia. The RevyPro® formulation enhances the activity of Revysol® and prothioconazole bringing exceptional complementary performance.

Reference: Efficacy of RevyPro® vs its single active ingredients.

Transport data added Aug 2024 n = 34 European Summary. Rhynchosporium data added Aug 2024 n = 11, European Summary (BASF)

In the field

RevyPro® has been trialed extensively in barley. Below shows RevyPro® applied at 1L/ha versus an Untreated plot.

Reference: BASF Winter Barley Variety trial, Aberdeenshire.

Left: RevyPro 1l/ha Right: Untreated plot

Photos taken 21st June 2024.

RevyPro® in Wheat

RevyPro® is a brilliant mix partner* in wheat, providing excellent flexibility to your fungicide programme. When used in mixes RevyPro® boosts the level of disease control and enhances the performance of the mix partner it is used with allowing you to be flexible with doses

*RevyPro® must be mixed with a fungicide from another mode of action when targeting Septoria

In the field

Even across a number of trials where RevyPro® has been used solo it has demonstrated its performance across key wheat diseases.

Disease Control

Reference: 9 BASF Trials in 2024. Applications at T2 with an overspray at T1. Programmes uniform within trials, not across trials.

Mixes are for trial purposes only. For BASF’s full compatibility list visit here

Mean Untreated yield: 7.80t/ha

Reference: ADAS trial 2022. Treatments applied at T1. Common overspray at T2

Photograph taken: 15th June 2022

Reference: BASF trials, 2024 n=2. Untreated 22%, severity of attack 13-31%.

Single T2 application at BBCH 39, assessment 34-37 days after application

Top